CNS Neuroscience & Therapeutics

Papers
(The H4-Index of CNS Neuroscience & Therapeutics is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The severity assessment of Parkinson's disease based on plasma inflammatory factors and third ventricle width by transcranial sonography805908745
Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2209
Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms206
Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2/GPX4 defense pathway99
Microglial/Macrophage polarization and function in brain injury and repair after stroke88
Neurovascular Unit: A critical role in ischemic stroke85
Exosomes from miRNA‐126‐modified endothelial progenitor cells alleviate brain injury and promote functional recovery after stroke67
Exercise, brain plasticity, and depression67
Pathogenesis and pathophysiology of idiopathic normal pressure hydrocephalus65
Quality of life in Parkinson's disease: A systematic review and meta‐analysis of comparative studies60
Abnormal dynamic functional connectivity in Alzheimer’s disease59
Caspase‐1 inhibition prevents neuronal death by targeting the canonical inflammasome pathway of pyroptosis in a murine model of cerebral ischemia56
Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma50
Acyl‐CoA synthetase long chain family member 4 plays detrimental role in early brain injury after subarachnoid hemorrhage in rats by inducing ferroptosis50
P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis49
Gut microbiota interacts with intrinsic brain activity of patients with amnestic mild cognitive impairment48
Bidirectional Brain‐gut‐microbiota Axis in increased intestinal permeability induced by central nervous system injury47
Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury46
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma44
Epidermal neural crest stem cell transplantation as a promising therapeutic strategy for ischemic stroke43
Development of early diagnosis of Parkinson's disease: Illusion or reality?40
Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer’s disease37
Phagocytic microglia and macrophages in brain injury and repair36
Taurine and oxidative stress in retinal health and disease35
Perioperative neurocognitive disorders: A narrative review focusing on diagnosis, prevention, and treatment35
Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases35
Regulatory T cells in ischemic stroke35
Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis‐related NLRP3 pathway33
Kynurenic acid in neurodegenerative disorders—unique neuroprotection or double‐edged sword?33
Gut bacterial profiles in Parkinson's disease: A systematic review32
Fisetin ameliorates cognitive impairment by activating mitophagy and suppressing neuroinflammation in rats with sepsis‐associated encephalopathy32
Recent advances and perspectives of postoperative neurological disorders in the elderly surgical patients31
AIM2 deletion enhances blood‐brain barrier integrity in experimental ischemic stroke31
Electroacupuncture ameliorates postoperative cognitive dysfunction and associated neuroinflammation via NLRP3 signal inhibition in aged mice31
Disrupted functional network connectivity predicts cognitive impairment after acute mild traumatic brain injury31
0.049226999282837